Daptomycin Patent Expiration
Daptomycin was first introduced by Cubist Pharmaceuticals Llc
Daptomycin Patents
Given below is the list of patents protecting Daptomycin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Dapzura Rt | US11173189 | Daptomycin formulations containing a combination of sorbitol and mannitol | Mar 11, 2041 | Baxter Hlthcare Corp |
| Daptomycin | US11759497 | Daptomycin formulations | Aug 28, 2038 | Hikma |
| Daptomycin | US12053502 | Daptomycin formulations | Aug 28, 2038 | Hikma |
| Daptomycin | US10357535 | Daptomycin formulations and uses thereof | Sep 11, 2033 | Hospira |
| Daptomycin | US9655946 | Daptomycin formulations and uses thereof | Sep 11, 2033 | Hospira |
| Cubicin | US9138456 | Lipopeptide compositions and related methods | Nov 23, 2030 | Cubist Pharms Llc |
| Cubicin Rf | US9138456 | Lipopeptide compositions and related methods | Nov 23, 2030 | Cubist Pharms Llc |
| Cubicin | US8003673 | Daptomycin for the treatment of biofilm and catheter salvage | Sep 04, 2028 | Cubist Pharms Llc |
| Cubicin | US8058238 | High purity lipopeptides |
Nov 28, 2020
(Expired) | Cubist Pharms Llc |
| Cubicin | US8129342 | High purity lipopeptides |
Nov 28, 2020
(Expired) | Cubist Pharms Llc |
| Cubicin | US6468967 | Methods for administration of antibiotics |
Sep 24, 2019
(Expired) | Cubist Pharms Llc |
| Cubicin | US6852689 | Methods for administration of antibiotics |
Sep 24, 2019
(Expired) | Cubist Pharms Llc |
| Cubicin | USRE39071 | Anhydro-and isomer-a-21978c cyclic peptides |
Jun 15, 2016
(Expired) | Cubist Pharms Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Daptomycin's patents.
Latest Legal Activities on Daptomycin's Patents
Given below is the list recent legal activities going on the following patents of Daptomycin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification Critical
| 20 Sep, 2023 | US11759497 |
| Recordation of Patent eGrant | 19 Sep, 2023 | US11759497 |
| Patent eGrant Notification | 19 Sep, 2023 | US11759497 |
| Recordation of Patent Grant Mailed Critical
| 19 Sep, 2023 | US11759497 |
| Patent Issue Date Used in PTA Calculation Critical
| 19 Sep, 2023 | US11759497 |
| Mail Patent eGrant Notification | 19 Sep, 2023 | US11759497 |
| Email Notification Critical
| 01 Sep, 2023 | US11759497 |
| Issue Notification Mailed Critical
| 30 Aug, 2023 | US11759497 |
| Dispatch to FDC | 09 Aug, 2023 | US11759497 |
| Application Is Considered Ready for Issue Critical
| 09 Aug, 2023 | US11759497 |
Daptomycin's Family Patents
